Correlation Between Arcellx and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Arcellx and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcellx and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcellx and Fate Therapeutics, you can compare the effects of market volatilities on Arcellx and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcellx with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcellx and Fate Therapeutics.
Diversification Opportunities for Arcellx and Fate Therapeutics
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Arcellx and Fate is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Arcellx and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Arcellx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcellx are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Arcellx i.e., Arcellx and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Arcellx and Fate Therapeutics
Given the investment horizon of 90 days Arcellx is expected to generate 6.45 times less return on investment than Fate Therapeutics. But when comparing it to its historical volatility, Arcellx is 2.27 times less risky than Fate Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Fate Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 272.00 in Fate Therapeutics on August 30, 2024 and sell it today you would earn a total of 45.00 from holding Fate Therapeutics or generate 16.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arcellx vs. Fate Therapeutics
Performance |
| Timeline |
| Arcellx |
| Fate Therapeutics |
Arcellx and Fate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arcellx and Fate Therapeutics
The main advantage of trading using opposite Arcellx and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcellx position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.| Arcellx vs. Nuvalent | Arcellx vs. Ventyx Biosciences | Arcellx vs. Amylyx Pharmaceuticals | Arcellx vs. Day One Biopharmaceuticals |
| Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |